Prometedor tratamiento para la enfermedad de Wilson / A promising treatment for Wilson’s disease

Científicos del Centro de Investigación Médica Aplicada (CIMA) de la Universidad de Navarra han diseñado un método prometedor de terapia génica para tratar esta enfermedad rara.
Este proyecto de un centro de investigación español ha atraído a inversores internacionales líderes en biotecnología formando Vivet Therapeutics, compañía emergente que ha captado 37,5 millones de euros en su primera ronda de financiación.
Scientists at CIMA at the University of Navarra have designed VTX801, a promising gene therapy method to treat Wilson’s disease. They expected to begin the first clinical trials on patients in 2018. The Massachusetts Eye and Ear Infirmary, associated with Harvard University, has participated in its development. This Spanish research project has attracted leading international investors in biotechnology by forming Vivet Therapeutics, an emerging company which has raised €37.5 million in its Series A financing round.